Tavoos Khavarmianeh Investment Bank Underwrites Behvazan Pharma's 23% Murabaha Bonds, Expecting 90.3 Billion Tomans Over Three Years

Tavoos Khavarmianeh Investment Bank (Takhavar) said in a Group B Codal disclosure on Wednesday, October 28, 2026 (6 Aban 1405), that it has accepted the underwriting and market-making commitment for the murabaha bonds of Behvazan Pharmaceutical Company (private joint stock), under the ticker "Sbhvz808". The bonds carry a stated yield of 23 percent a year, and the event date is October 27, 2026 (5 Aban 1405).

Total income from the commitment is 903,000 million rials (90.3 billion tomans): 3,000 million rials (300 million tomans) of underwriting income recognised right after the subscription, and 900,000 million rials (90 billion tomans) of market-making income to be recognised over three years. The notice does not state the issue size or the subscription date.